Jan 14, 2026
921:892
For every 892 shares held, investors received 921. The price per share adjusted from $36.80 to $35.64.
The split itself did not change the total investment value.
Genovate Biotechnology Co., Ltd. (TPEX:4130) operates in the Pharmaceuticals: major industry.
Genovate Biotechnology Co., Ltd. company overviewGenovate Biotechnology Co., Ltd.'s most recent stock split was on January 14, 2026. It was a 921-for-892 forward split, so shareholders received 921 shares for every 892 they held.
Genovate Biotechnology Co., Ltd. (TPEX:4130) has split its stock 6 times: a 21-for-20 split on July 17, 2019, a 51-for-50 split on August 25, 2020, a 51-for-50 split on September 10, 2021, a 103-for-100 split on August 21, 2024, a 51-for-50 split on August 20, 2025, and a 921-for-892 split on January 14, 2026.
Genovate Biotechnology Co., Ltd. has split its stock 6 times. This history records 6 forward splits between July 17, 2019 and January 14, 2026.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Genovate Biotechnology Co., Ltd.'s 921-for-892 split on January 14, 2026, every 892 shares became 921 shares.
Genovate Biotechnology Co., Ltd. has not announced a new split in our records. Its most recent split was on January 14, 2026, less than a year ago. Companies announce splits in advance, and any new TPEX:4130 split will appear on this page.
Already premium?